Visión generalGráficoNoticiasTraderScreen

UBS Knock-Out JNJ/  DE000UK4N123  /

UBS Investment Bank
14/11/2024  16:37:52 Diferencia-0.230 Bid16:37:52 Ask16:37:52 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
0.620EUR -27.06% 0.620
Volumen de oferta: 10,000		 0.630
Tamaño/ Volumen/ Formato de Ask: 10,000		 Johnson and Johnson 144.9741 USD 31/12/2078 Call
TeleTrader 15/10 J&J's Q3 sales rise by 5.2% to $22.5B
TeleTrader 01/10 J&J: Over $2B to be put into new facility in North Carolina
TeleTrader 10/09 D. S. Davis retires as director of Johnson & Johnson
TeleTrader 20/08 Johnson & Johnson to buy V-Wave for up to $1.7B
GlobeNewswire 14/08 BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
TeleTrader 17/07 J&J's Q2 sales up by 4.3% to $22.4 billion
GlobeNewswire 28/05 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
TeleTrader 01/05 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 17/04 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 10/04 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 05/04 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 26/03 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 15/03 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 06/03 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 27/01 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 24/01 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 23/01 J&J to pay $700M in talc powder probe settlement
TeleTrader 23/01 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 23/01 Johnson & Johnson Q4 earnings preview
TeleTrader 22/01 Earnings preview: Tesla takes center stage
TeleTrader 08/01 J&J to buy biotech company Ambrx for $2B
GlobeNewswire 04/12/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
GlobeNewswire 04/12/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
TeleTrader 07/11/2023 J&J to begin trials with surgical robot
TeleTrader 17/10/2023 J&J's Q3 sales up 6.8% to $21.4 billion